• Héctor Eloy Tamez-Pérez, Enrique Delgadillo-Esteban, and Alejandra Lorena Tamez-Peña.
• . Research Subdirector, Faculty of Medicine and University Hospital "Dr. José Eleuterio González", Autonomous University of Nuevo León, Monterrey, México.
• Rev Assoc Med Bras (1992). 2020 Mar 1; 66 (3): 334337334-337.

ObjectiveTo present the results of metabolic control in patients with type 2 Diabetes Mellitus from a private clinic in Northern Mexico.MethodsThis cross-sectional study used retrospective data obtained from electronic records from a private outpatient clinic at the end of 2018. Inclusion criteria were a diagnosis of T2DM and age ≥ 18 years. Baseline characteristics (age, gender, drug use) were reported. The achievement of glycated hemoglobin goals was established as <7%.ResultsA total of 3820 patients were evaluated. Their mean age was 59.86 years (+/-15.01). Of the population, 46.72% were men, and 53.28% were women. Glycated hemoglobin goals were adequate in 1872 (54%) patients. There were 3247 patients (85%) treated with oral medications, of which 1948 (60%) reported glycated hemoglobin less than 7%. Insulin use was reported in 573 (15%) patients, with 115 (20%) reporting glycated hemoglobin less than 7%. The most frequently used basal insulin was glargine in 401 (70%) patients.ConclusionsOur findings are clearly higher than the control rate reported by our national health surveys of 25% with glycated hemoglobin < 7%, but similar to that reported in other countries. The most commonly used therapeutic scheme was the combination of oral hypoglycemic agents. The percentage of cases that include insulin in their treatment was lower. Clinical inertia to insulin initiation and intensification has been defined as an important cause of this problem.

25 keywords...

hide…